Tango Therapeutics shareholders approve doubling authorized shares to 400M, elect new director

Tango Therapeutics, Inc.

Shareholders approved amendment to increase authorized common stock from 200M to 400M shares (85.8M for, 11M against).
Lesley Ann Calhoun elected as Class I director with 73.1M votes for, 10.5M withheld.
Ratification of PricewaterhouseCoopers as auditor for FY2025 passed with 96.7M for.
Non-binding say-on-pay passed; annual advisory vote frequency approved (73M votes for one year).

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Tango Therapeutics, Inc.: Amendment to increase authorized shares of common stock from 200,000,000 to 400,000,000 (effective 2025-06-05).

Change: charter amendment
Effective: 2025-06-05

Exact text from the filing

The certificate of amendment of the Company’s Second Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”), was filed with the Secretary of State of the State of Delaware on June 5, 2025 and became effective upon filing.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Tango Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-137032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.